3 Healthcare Stocks Walking a Fine Line
Jazz Pharmaceuticals (JAZZ) Stock Trades Up, Here Is Why
Jazz Pharmaceuticals (NASDAQ:JAZZ) Surprises With Q4 CY2025 Sales
– Record total revenues of $4.3 billion in 2025 (+5% YoY) and $1.2 billion (+10% YoY) in 4Q25 –
Jazz Pharmaceuticals Earnings: What To Look For From JAZZ
DUBLIN , Feb. 17, 2026 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in the following investor conferences:
1 Safe-and-Steady Stock with Competitive Advantages and 2 We Brush Off
1 Cash-Producing Stock with Impressive Fundamentals and 2 We Avoid
DUBLIN , Feb. 10, 2026 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced its fourth quarter and full year 2025 financial results will be reported on February 24, 2026, after...